News

Precise mapping of a patient’s brain can enable a wider range of treatments, writes DR ROWLAND ILLING, chief medical officer ...
New cost-effective RNA blood test can test for Parkinson's and other neurodegenerative diseases long before symptoms emerge.
Traditionally overlooked in Parkinson’s research, tRFs (transfer RNA fragments) are small RNA molecules with the potential to reveal significant changes in the body linked to neurodegeneration. The ...
Alzheimer’s blood tests may one day allow patients and their doctors to track their individual progress in reducing risk, ...
Health care providers, insurers and pharmaceutical companies are widely interested in the use of generative AI in their ...
Parkinson’s Disease is often diagnosed only after significant brain damage has occurred, when most relevant neurons are ...
The development of cost-effective and accessible biomarkers could improve diagnostic ... to evaluate the long-term diagnostic stability of Parkinson’s disease and assess the accuracy of initial ...
Hebrew University researchers say their innovative test can find tRNA fragments unique to the neurodegenerative disease ...
Researchers Identify a Potential Biomarker of Parkinson's Disease Progression Nov. 12, 2024 — Researchers have identified a potential biomarker of Parkinson's disease progression. According to ...
For the third year, the Michael J. Fox Foundation organized a concert benefit at Belmont University's Fisher Center for ...
An £80 blood test could help predict those who will develop Parkinson’s before they show symptoms of the disease, a new study ...
A new study by the University of Turku and Turku University Hospital, Finland, found that a significant proportion of ...